R&D Tax Credit Calculator
Estimate your potential UK R&D tax relief under the merged R&D Expenditure Credit (RDEC) scheme, or the Enhanced R&D Intensive Support (ERIS) scheme for loss-making, R&D-intensive SMEs.
Qualifying R&D Expenditure
PAYE / NIC Cap (Optional)
R&D Tax Credit Calculator UK 2026
Our R&D Tax Credit Calculator estimates the potential value of a Research and Development tax relief claim under the UK’s current merged R&D Expenditure Credit (RDEC) scheme, and the Enhanced R&D Intensive Support (ERIS) scheme for loss-making, R&D-intensive SMEs. Figures shown are illustrative estimates based on the rules in force for accounting periods beginning on or after 1 April 2024 – always confirm eligibility and figures with a qualified accountant or R&D tax specialist before submitting a claim.
How the Merged R&D Scheme Works
For accounting periods beginning on or after 1 April 2024, most companies – regardless of size – claim under a single merged R&D Expenditure Credit (RDEC) scheme. It replaced the separate pre-2024 SME and RDEC regimes.
| Feature | Merged RDEC Scheme |
|---|---|
| Credit rate | 20% of qualifying R&D expenditure |
| Treatment | Taxable, above-the-line credit |
| Applies to | All companies, profitable or loss-making (except R&D-intensive loss-making SMEs, who may prefer ERIS) |
| Net benefit (25% CT rate) | Approximately 15% of qualifying spend |
| Net benefit (19% notional rate) | Approximately 16.2% of qualifying spend |
How to Use This Calculator
- Enter your accounting period start date – the merged scheme and ERIS only apply from 1 April 2024 onward.
- Select your company’s profit or loss position for the period.
- If profitable, choose your Corporation Tax position – small profits rate, main rate, or a custom marginal rate.
- If loss-making, indicate whether your R&D spend is at least 30% of total expenditure, or let the calculator work it out from your total expenditure figure.
- Enter your qualifying R&D expenditure across staff costs, externally provided workers, subcontractors, consumables, software and clinical trial costs.
- Optionally enter your PAYE/NIC liability to check whether any cash credit would be capped.
- Click Calculate R&D Relief to see your estimated net benefit.
What Is Enhanced R&D Intensive Support (ERIS)?
ERIS is a more generous route available only to loss-making SMEs whose qualifying R&D expenditure is at least 30% of total expenditure for the period. Rather than the 20% RDEC credit, ERIS gives:
- An additional 86% deduction on qualifying R&D costs (186% total deduction including the normal 100%)
- A payable tax credit worth 14.5% of the resulting surrenderable loss
A company can claim under the merged scheme or ERIS for the same expenditure, but not both. Where a loss-making SME is R&D-intensive, ERIS is usually the more valuable route, though the exact outcome depends on the surrenderable loss available and the PAYE/NIC cap.
The PAYE/NIC Cap
Cash credits paid to loss-making companies under both the merged scheme and ERIS are subject to a cap, designed to deter fraudulent claims from companies with little genuine UK employment. For a normal 12-month accounting period, the cap is GBP20,000 plus 300% of the company’s total UK PAYE and NIC liability for the period. Shorter accounting periods can have a proportionately reduced GBP20,000 element – this calculator assumes a full 12-month period throughout. Claims above the cap are generally carried forward or used to reduce a future Corporation Tax liability rather than paid as cash immediately – check the current HMRC guidance for your specific circumstances.
Who Counts as an SME for R&D Purposes?
For R&D tax relief purposes, a company is generally treated as an SME if it has fewer than 500 employees, and either turnover under EUR100 million or a balance sheet total under EUR86 million. Companies above these thresholds are treated as large companies, and ERIS is not available to them – only the merged RDEC scheme applies.
What Expenditure Qualifies for R&D Relief?
| Cost Category | Treatment |
|---|---|
| Staff costs | Salaries, employer NIC and pension contributions for staff directly engaged in qualifying R&D – qualifies in full |
| Externally provided workers | Agency/staffing provider costs – 65% qualifies, subject to conditions |
| Subcontractor costs | Payments for subcontracted R&D work – 65% qualifies, subject to conditions and allocation rules |
| Consumables and materials | Items consumed or transformed in the R&D process – qualifies in full |
| Software | Software licences used directly in R&D – qualifies in full |
| Clinical trial volunteers | Payments to volunteers in clinical trials – qualifies in full where conditions are met |
Subcontracting and overseas expenditure rules changed materially under the merged scheme, including restrictions on work carried out overseas. This calculator applies a simplified 65% restriction and does not model the full subcontractor allocation or overseas restriction rules – always check current HMRC guidance.
What If My Accounting Period Started Before April 2024?
If your accounting period began before 1 April 2024, your claim falls under the older, separate SME and RDEC schemes rather than the merged scheme or ERIS modelled by this calculator. Those legacy rules had different rates and mechanics, including the pre-2023 130% SME enhancement and different payable credit rates. Speak to an R&D tax specialist about the rules that applied to your specific period.
Frequently Asked Questions
What is the R&D tax credit merged scheme?
The merged R&D Expenditure Credit (RDEC) scheme is the single UK R&D tax relief regime for accounting periods beginning on or after 1 April 2024. It gives a taxable, above-the-line credit worth 20% of qualifying R&D expenditure, replacing the separate pre-2024 SME and RDEC schemes for most companies.
Who qualifies as an R&D-intensive SME?
A loss-making SME is generally considered R&D-intensive if its qualifying R&D expenditure is at least 30% of its total expenditure for the period. R&D-intensive SMEs may claim under Enhanced R&D Intensive Support (ERIS) instead of the merged RDEC scheme, which is usually more generous for genuine loss-making startups.
Can I claim under both the merged scheme and ERIS?
No. A company can claim relief on the same qualifying expenditure under only one scheme for a given accounting period – either the merged RDEC scheme or ERIS, where eligible. Most R&D-intensive, loss-making SMEs find ERIS more valuable, but the calculation should be checked for each specific claim.
What is the PAYE/NIC cap on R&D tax credits?
The PAYE/NIC cap limits the cash credit a company can receive under the merged scheme or ERIS to GBP20,000 plus 300% of its total UK PAYE and National Insurance liability for the period, assuming a 12-month accounting period. It was introduced to deter fraudulent claims from companies with minimal genuine UK employment.
What if my accounting period started before 1 April 2024?
Periods starting before 1 April 2024 fall under the older, separate SME and RDEC schemes rather than the merged scheme or ERIS. Rates and mechanics differed under those legacy rules. This calculator only models the current merged scheme and ERIS – speak to a specialist about older periods.
How is subcontractor and externally provided worker expenditure restricted?
Under the simplified treatment used by this calculator, only 65% of externally provided worker (EPW) and subcontractor costs qualify for R&D relief. The actual rules under the merged scheme also include allocation rules between the company that decided to undertake the R&D and any subcontractor, plus restrictions on overseas expenditure, which this calculator does not model in detail.
What documents do I need to submit an R&D tax credit claim?
HMRC requires an Additional Information Form to be submitted before or alongside the Company Tax Return containing the R&D claim, setting out the qualifying expenditure, project details and agent information. This calculator does not prepare or submit any claim documentation.